Related Experiment Video
Updated: May 22, 2026

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
Poor prognosis in chronic heart failure patients with reduced ejection fraction in China
Zhongwei Cheng1, Kongbo Zhu, Taibo Chen
1Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Insights
Heart failure patients in China with reduced ejection fraction (LVEF ≤ 45%) face poor prognosis. Those with severely reduced LVEF (≤ 35%) experienced significantly higher mortality and readmission rates.
Area of Science:
- Cardiology
- Clinical Research
- Public Health
Background:
- High mortality rates in heart failure (HF) patients with reduced ejection fraction present a significant challenge for Chinese cardiologists.
- Understanding the prognosis of chronic HF patients in China is crucial for improving patient outcomes.
Purpose of the Study:
- To evaluate the prognosis of heart failure patients with left ventricular ejection fraction (LVEF) ≤ 45% in China.
- To identify predictors of mortality and cardiovascular readmission in this patient population.
Main Methods:
- A single-center, retrospective study enrolled 187 consecutive HF patients with LVEF ≤ 45% between 2007 and 2009.
- Patients were categorized into two groups: LVEF ≤ 35% (n=83) and LVEF 36% to 45% (n=104).
- Primary outcome was all-cause mortality; secondary outcome was all-cause mortality or first cardiovascular readmission, with a median follow-up of 18 months.
Main Results:
- All-cause mortality was significantly higher in the LVEF ≤ 35% group (27%) compared to the LVEF 36% to 45% group (14%) (P=.025).
- The combined endpoint of all-cause mortality or first cardiovascular readmission was also significantly higher in the LVEF ≤ 35% group (53%) versus the LVEF 36% to 45% group (32%) (P=.003).
- Predictors of all-cause mortality included advanced age, higher NYHA functional class, chronic kidney disease, and discharge on oral beta-blockers and statins.
Conclusions:
- The prognosis for chronic heart failure patients with LVEF ≤ 45% in China is poor, particularly for those with LVEF ≤ 35%.
- Further efforts are needed from cardiologists to improve the management and outcomes of HF patients in China.
- Identifying predictors of mortality can aid in risk stratification and targeted interventions.
Abstract:
Most Chinese cardiologists are challenged by the high mortality rate of heart failure (HF) in patients with reduced ejection fraction in China. This study was designed as a single-center, retrospective study. All consecutive HF patients with left ventricular ejection fraction (LVEF) ≤ 45% from January 1, 2007, to December 31, 2009, were enrolled. The primary outcome was all-cause mortality. The secondary outcome was all-cause mortality or the first cardiovascular readmission event. A total of 187 patients comprised the study population, classified into two groups: LVEF ≤ 35% (n=83) and LVEF 36% to 45% (n=104). The median follow-up was 18 months (2-41 months). All-cause mortality was 27% among patients with LVEF ≤ 35%, as compared with 14% among those with LVEF 36% to 45% (P=.025). All-cause mortality or first cardiovascular readmission rates were 53% and 32% among patients with LVEF ≤ 35% and 36% to 45% (P=.003), respectively. The predictors of all-cause mortality were advanced age and New York Heart Association functional class, chronic kidney disease, oral β-blockers, and statins at discharge. The prognosis of chronic HF patients with LVEF ≤ 45% was poor in China, especially for patients with LVEF ≤ 35%. Cardiologists should provide further efforts to improve the prognosis of HF in Chinese patients.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure I: Introduction
Heart Failure VII: Nursing Interventions
Heart Failure V: Medical Management
Heart Failure II: Pathophysiology